Current research insights into the role of CTLA ‐4 in hepatitis B virus ( HBV ) infection
Journal of Viral Hepatitis · 2024
DOI: 10.1111/jvh.13958 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Viral Hepatitis, 2024. Verfasst von Qi Gu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: CTLA-4 Antigen, Hepatitis B, Chronic, Hepatitis B virus, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Ji'nan Science and Technology Development Project, Natural Science Foundation of Jiangsu Province, Nanjing Medical Science and Technique Development Foundation.
Abstract (Originalsprache)
Chronic hepatitis B virus (HBV) infection is a significant global public health concern, and the clearance of HBV is closely linked to the activity of HBV‐specific T cells, which is regulated by various co‐suppressor molecules. Cytotoxic T lymphocyte‐associated antigen 4 (CTLA‐4) is among these co‐suppressor molecules which induces T cell exhaustion by competitively inhibiting CD28 and dampening the function of HBV‐specific T cells. CTLA‐4 also plays a role in the regulation of T helper (Th) cell differentiation and influences cytokine release. In addition, CTLA‐4 can impact glucose metabolism in hepatocellular carcinoma through its interaction with T regulatory (Treg) cells. This review aims to provide a comprehensive overview of the existing literature related to the role of CTLA‐4 in HBV patients across different subsets of T cells. Additionally, we propose a discussion on the possible mechanisms through which CTLA‐4 may contribute to HBV infection, as well as the development of HBV‐induced cirrhosis and hepatocellular carcinoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.
- Institute of Viruses and Infectious Diseases, Nanjing University, Nanjing, Jiangsu, China.
- Department of Infectious Diseases, Nanjing Drum Tower Hospital, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
- Department of Infectious Diseases, Nanjing Drum Tower Hospital, Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
ORCID-Profile: Chao Wu
Förderung
- Ji'nan Science and Technology Development Project
- Natural Science Foundation of Jiangsu Province
- Nanjing Medical Science and Technique Development Foundation
- Natural Science Foundation of Shandong Province
- National Natural Science Foundation of China
Zitieren
APA
Gu, Q., Yin, S., Tong, X., Rui, F., Zhu, Y., Ma, X., Huang, R., Wu, C., & Li, J. (2024). Current research insights into the role of CTLA ‐4 in hepatitis B virus ( HBV ) infection. Journal of Viral Hepatitis. https://doi.org/10.1111/jvh.13958
Vancouver
Gu Q, Yin S, Tong X, Rui F, Zhu Y, Ma X, et al. Current research insights into the role of CTLA ‐4 in hepatitis B virus ( HBV ) infection. Journal of Viral Hepatitis. 2024. doi:10.1111/jvh.13958
BibTeX
@article{Gu2024,
author = {Gu, Qi and Yin, Shengxia and Tong, Xin and Rui, Fajuan and Zhu, Yixuan and Ma, Xiaoyan and Huang, Rui and Wu, Chao and Li, Jie},
title = {Current research insights into the role of CTLA ‐4 in hepatitis B virus ( HBV ) infection},
journal = {Journal of Viral Hepatitis},
year = {2024},
doi = {10.1111/jvh.13958}
}
EUVIMED